1. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers. (December 2013) Authors: Gutenberg, A.; Bock, H. C.; Brück, W.; Doerner, L.; Mehdorn, H. M.; Roggendorf, W.; Westphal, M.; Felsberg, J.; Reifenberger, G.; Giese, A. Journal: British journal of neurosurgery Issue: Volume 27:Number 6(2013:Dec.) Page Start: 772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗